Core Viewpoint - Tilray Brands, Inc. will announce its financial results for the second quarter of fiscal year 2026 on January 8, 2026, after market close [1] Group 1: Financial Results Announcement - The financial results will cover the period ending November 30, 2025 [1] - A live conference call and audio webcast will be held on the same day at 4:30 PM Eastern Time to discuss these results [2] - Investors can submit questions via Robinhood and Say Technologies until January 7, 2026 [2] Group 2: Company Overview - Tilray is a leading global lifestyle and consumer packaged goods company with operations in multiple regions including Canada, the United States, Europe, Australia, and Latin America [3] - The company focuses on cannabis, beverage, wellness, and entertainment sectors, aiming to elevate lives through moments of connection [3] - Tilray supports over 40 brands in more than 20 countries, offering a range of products including cannabis, hemp-based foods, and craft beverages [3]

Core Viewpoint - Organigram Global Inc. (OGI) has shown robust growth and operating leverage, leading to margin expansion, which justifies a buy rating initiated last August. The stock has increased by 31% since the rating due to solid Q4 performance [1]. Company Analysis - The company has demonstrated strong growth metrics, contributing to a favorable investment outlook. The increase in stock price reflects positive market sentiment and operational efficiency [1]. Market Trends - The analysis highlights the importance of thorough research and understanding of financial statements and market trends, which are critical for identifying undervalued investment opportunities in mid and small-cap companies [1].

Core Viewpoint - Tilray Brands, Inc. is set to release its financial results for the second fiscal quarter ending November 30, 2025, on January 8, 2026, after market close [1] Group 1: Financial Results Announcement - The financial results will be announced after the financial markets close on January 8, 2026 [1] - A live conference call and audio webcast will be held at 4:30 PM Eastern Time on the same day to discuss these results [2] Group 2: Investor Engagement - Investors can submit and upvote questions via Robinhood and Say Technologies from now until January 7, 2026 [3] - Questions can be submitted on the Tilray stock detail page on Robinhood or through the Say Technologies platform [3] Group 3: Company Overview - Tilray is a leading global lifestyle and consumer packaged goods company with operations in multiple regions including Canada, the United States, Europe, Australia, and Latin America [3] - The company focuses on cannabis, beverage, wellness, and entertainment sectors, aiming to elevate lives through moments of connection [3] - Tilray supports over 40 brands in more than 20 countries, offering a range of products including cannabis offerings, hemp-based foods, and craft beverages [3]

Rescheduling Cannabis from Schedule I to Schedule III will help to foster a fair and supportive environment for the industry and reduce unnecessary obstacles to growthLAS VEGAS, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings, Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, is sharing the following commentary regarding the December 18, 2025 Executive Order that directs the Attorney General to expedite completion of the process ...

Core Insights - 420 Investor was launched in 2013, coinciding with Colorado's legalization of cannabis for adult use, and has now transitioned its services to Seeking Alpha [1] - Alan Brochstein, a pioneer in cannabis investment analysis, has extensive experience in the financial sector and has been focusing on cannabis stocks since 2013 [1] - The investing group 420 Investor covers 20 cannabis stocks, providing investment news, earnings report previews, and post-report analyses [1] Company and Industry Overview - 420 Investor offers a range of resources including model portfolios, weekly videos with chart analysis, summary pieces, a monthly newsletter, and a chat feature for investor inquiries [1] - Alan Brochstein is also the managing partner of New Cannabis Ventures, which has been a key provider of financial information in the cannabis industry since 2015 [1]

Cresco Labs ( CRLBF ) and other US MSOs fell last week as traders took profits on news of federal cannabis rescheduling. There had been a sector rally leading up to the news. The Executive OrderWelcome to the home of The Cannabis Report. I cover the cannabis sector and other sectors. I am most interested in technical stock analysis, option strategies, small cap strategies, and emerging markets. Feel free to contact me with any questions about publicly traded stocks in the cannabis industry.Analyst’s Disclos ...

Market Overview - Markets experienced moderate gains due to softer inflation data and stable unemployment, which renewed investor confidence in a potential 2026 rate cut by the Federal Reserve [2] - The Dow Jones Industrial Average and S&P 500 advanced, supported by broad-based sector strength, while the Nasdaq Composite rebounded, led by a tech recovery [2] Earnings Highlights - Micron Technology Inc. exceeded expectations and raised its guidance, leading to a rally in AI-related semiconductor stocks [3] - Nike Inc. shares declined after the company expressed caution regarding global demand, particularly in China, raising concerns about consumer strength [3] - FedEx Corp. reported solid quarterly results, enhancing confidence in global shipping demand, while Carnival Corp. provided optimistic forward guidance, indicating strong consumer appetite for travel [4] Sector Performance - Cyclical and dividend-paying stocks gained traction as portfolio managers positioned for a potentially lower-rate environment in 2026 [3] - Transportation and travel sectors showed resilience, with FedEx and Carnival Corp. signaling robust demand and strong bookings [4] Notable Stock Movements - Cannabis stocks, including Tilray Brands Inc. and Canopy Growth Corp., rallied following reports of potential rescheduling of marijuana by President Trump, which could ease tax burdens [6] - Carnival Corporation reported record earnings and reinstated its quarterly dividend, forecasting adjusted net income of about $3.5 billion for 2026, reflecting strong demand [7] - Caterpillar Inc. emerged as the top-performing Dow stock in 2025, rising over 62% and adding approximately $1.7 billion in value to significant stakeholders [8] Market Sentiment - JPMorgan Chase indicated that the generative-AI narrative has peaked, suggesting that 2026 will focus more on profits rather than hype, with investors likely to favor companies demonstrating clear ROI [9] - Meta Platforms Inc. is noted as the most underperforming stock among the Magnificent 7, trading about 19% below its 52-week high, with potential for a year-end rebound [10][11] - Novo Nordisk A/S faced challenges as Eli Lilly and Co. gained market share in the weight-loss drug sector, leading to a decline in Novo's stock [12]

Financial Data and Key Metrics Changes - For fiscal year 2025, the company reported total net sales of $19.1 million, a slight decrease from $19.5 million in the prior year [16][20] - The operating loss for fiscal 2025 was approximately $2.1 million, improved from a loss of $3.3 million in 2024 [6][23] - Adjusted non-GAAP EBITDA improved from a loss of $1.7 million in 2024 to a loss of $900,000 in 2025 [6][25] - Gross profit margin for the fourth quarter of fiscal 2025 was 59%, up from 54% in the prior year [21] Business Line Data and Key Metrics Changes - E-commerce direct-to-consumer sales for the fourth quarter of fiscal 2025 were $3.5 million, a 6% year-over-year decrease [16][17] - The wholesale business generated $1.2 million in net sales for the fourth quarter of fiscal 2025, a 25% increase compared to $900,000 in the same quarter of fiscal 2024 [19][20] - For fiscal year 2025, the wholesale business generated net sales of $4.5 million, up from $3.8 million in 2024 [20] Market Data and Key Metrics Changes - Distribution for the new beverage brand, Oasis, has expanded to nine states, with improving case sell-through and growing distributor engagement [7][8] - E-commerce represented 77% of total net sales for fiscal year 2025, down from 81% in the prior year [17] Company Strategy and Development Direction - The company is focused on scaling the Oasis brand responsibly while driving efficient, profitable direct-to-consumer growth [29] - The strategy includes preserving margins and capital discipline while evaluating strategic opportunities aligned with regulatory strength [29] - The company aims to capitalize on the evolving regulatory environment, particularly with the recent executive order from the White House [12][13] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's position in the evolving regulatory landscape, highlighting the potential for increased demand for CBD products [12][30] - The company believes that the heavy lifting of the turnaround is largely behind them, with fiscal 2026 focused on improving financial performance [30] - Management noted that the executive order could lead to significant demand for quality CBD products, particularly among Medicare consumers [46] Other Important Information - The company eliminated over $7 million in annual accrued preferred dividend obligations, significantly improving working capital [9][26] - The company has a strong liquidity position entering calendar 2026, with cash and cash equivalents of approximately $2.2 million [26][28] - The NYSE American confirmed that all prior compliance deficiencies had been resolved, reflecting progress in financial stability [11] Q&A Session Summary Question: What will be the key driver of growth in 2026? - Management believes there are growth opportunities in both the core cbdMD brand and the beverage side, with visibility on growth through November [35] Question: Can you explain the decline in direct-to-consumer business? - Management indicated that the decline is tied to organizational changes and is trending slightly up over prior year periods [36][37] Question: What is the timeline for Medicare coverage of CBD products? - Management mentioned that a pilot program is expected to start on April 1st, with potential for significant demand increase [39][40] Question: How will the executive order impact the business? - Management views the executive order as a potential game changer, with significant demand for CBD products expected in the coming years [45][46] Question: How are you prioritizing growth investments for fiscal 2026? - Management indicated that the next quarter will likely see more investment in the Oasis side, with ongoing evaluations based on regulatory developments [66]

watch nowPresident Donald Trump's move Thursday to sign an executive order easing federal restrictions on marijuana — and clearing the way for a Medicare pilot program covering CBD — caps a coordinated, yearlong push by the cannabis industry that combined traditional lobbying, sizable political donations, data-driven messaging and direct outreach to the president's inner circle, industry insiders told CNBC.Despite long-standing GOP opposition to loosening drug laws — including a small wave of bills from law ...

Core Insights - cbdMD, Inc. reported its financial results for the fiscal year ending September 30, 2025, highlighting operational and financial improvements for the third consecutive year [1][2]. Financial Performance - The company experienced a loss from operations of $2.1 million, an improvement of $1.2 million from a $3.3 million loss in fiscal 2024 [3][12]. - Net sales for fiscal 2025 totaled $19.1 million, a slight decrease from $19.5 million in fiscal 2024 [12]. - Gross profit remained stable at 62% for both fiscal years 2025 and 2024 [12]. - The net loss attributable to common shareholders was approximately $4.3 million, or $0.51 per share, compared to a net loss of approximately $7.7 million, or $14.29 per share in fiscal 2024 [12][18]. Balance Sheet and Capital Structure - The net book value improved from under $2.0 million to approximately $7.2 million at year-end due to balance-sheet actions, including the conversion of Series A preferred equity [3][12]. - The company raised an additional $2.25 million in gross proceeds from the sale of Series C Convertible Preferred Stock to strengthen its balance sheet [3][12]. - As of September 30, 2025, the company had $2.3 million in cash and working capital of approximately $3.4 million, compared to $2.4 million in cash and negative $2.2 million in working capital at the same time in 2024 [12][18]. Business Developments - The Herbal Oasis brand expanded into Texas through a distribution partnership, establishing distribution in multiple states including North Carolina, Florida, Alabama, and Minnesota [6]. - The company emphasized its commitment to safety, quality, and scientific rigor in its operations, having invested millions in GMP manufacturing and compliance systems [4][5]. Regulatory Environment - cbdMD expressed optimism regarding the White House's executive order on cannabinoid decriminalization, which could lead to significant investments and support for the reimbursement of full-spectrum hemp for seniors [4][5]. - The company believes that increasing regulatory clarity will encourage additional research and institutional investment in the cannabinoid category [5].